Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1993Movement Disorders

Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAbbey J. HughesJohns Hopkins UniversitySBSusan BishopMiddlesex HospitalBKB. KleedorferMiddlesex Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hughes et al. (1993) studied this question.

synapsesocial.com/papers/6a11d00fa84ddbb210fd4ad0https://doi.org/10.1002/mds.870080208
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Off‐period belching due to a reversible disturbance of oesophageal motility in Parkinso's disease and its treatment with apomorphine1989 · 39 citations
  2. 2Sublingual apomorphine and Parkinson's disease.1989 · 43 citations
  3. 3ON-OFF FLUCTUATIONS IN PARKINSON'S DISEASE1984 · 278 citations
  4. 4Similarities between Neurologic Effects of L-Dopa and of Apomorphine1970 · 272 citations